2024-03-11 12:13:19 ET
More on Lexicon Pharmaceuticals
- Lexicon Pharmaceuticals Putting The Pieces Together, But Much Is Left To Do
- Lexicon Pharma: Inpefa's Early Clinical Benefits, Rehospitalization Data May Unlock Significant Value
- Lexicon Pharmaceuticals: Navigating The Competitive HFpEF Landscape (Rating Downgrade)
- Lexicon announces oversubscribed $250M private placement of equity securities
- Lexicon Pharmaceuticals to offer up to $75M in common stock under agreement
Read the full article on Seeking Alpha
For further details see:
Lexicon Pharmaceuticals GAAP EPS of -$0.20 beats by $0.02, revenue of $0.7M misses by $0.54M